HomeClinical TopicsFDA approves first generic versions of Cymbalta

FDA approves first generic versions of Cymbalta

Author(s):

On Dec. 11, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta (duloxetine delayed-release capsules). Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content